Lyphochek Urine Toxicology Control MiniPak (A human urine drugs of abuse control)

AU/NZ SKREEN, Cutoff -30%, 20mL

AU/NZ SKREEN, Cutoff +25%, 20mL

AU/NZ SKREEN, 3X Cutoff, 20mL

STAT-SKREEN, Cutoff -25%, 20mL

STAT-SKREEN, 3X Cutoff, 20mL

STAT-SKREEN-H, Cutoff +50%, 20mL

STAT-SKREEN-H, Cutoff -50%, 20mL

STAT-SKREEN-H, Cutoff +25%, 20mL

STAT-SKREEN-H, Cutoff -25% 20mL

STAT-SKREEN-H, 3X Cutoff, 20mL

AU/NZ SKREEN, Cutoff -50%, 5mL

AU/NZ SKREEN, Cutoff +50%, 5mL

AU/NZ SKREEN, Cutoff -50%, 20mL

AU/NZ SKREEN, Cutoff +50%, 20mL

SERIES IX, CUTOFF 3X, 6x20mL

Drugs of Abuse Level 1 Control 1 X 15 mL

Drugs of Abuse Level 2 Control 1 X 15 mL

Multi-analyte Negative Control (2 x 15 mL)Multi-analyte Positive Control (2 x 15 mL)

HairCheck-DT (Cocaine) is an ELISA test kit used for qualitative detection of Cocaine in head hair with a cutoff of 300 pg/mg of hair. Kit is comprised of 4 component packages: Microplates, Conjugate Reagents, Common Reagents, and Calibrator/Controls.

The Randox Multidrug Control Level 1 is intended for use in the Quality Control of Methamphetamine, Barbiturates, Cocaine, Methadone and Opiates assays.

The Randox Multidrug Control Level 2 is intended for use in the Quality Control of Methamphetamine, Barbiturates, Cocaine, Methadone and Opiates assays.

The Randox EDDP Control - Level 1 is intended for use in the Quality Control of the 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) assay. The EDDP Control - Level 1 contains the specific drug EDDP.

The Randox EDDP Control - Level 2 is intended for use in the Quality Control of the 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) assay. The EDDP Control - Level 2 contains the specific drug EDDP.

This product is intended for in vitro diagnostic use in the quality control of drug residue analysis on clinical chemistry systems. TheDrug Controls are for the control of accuracy and precision.

This product is intended for in vitro diagnostic use in the quality control of drug residue analysis on clinical chemistry systems. The Drug Controls are for the control of accuracy and precision.

This product is intended for in vitro diagnostic use in the quality control of drug residue analysis on clinical chemistry systems. The Drug Controls are for the control of accuracy and precision.

Therapeutic Drug Markers (TDM) Linearity Verifiers are an in vitro diagnostic product used to assess the linearity of the Roche Systems for Acetaminophen, Amikacin, Carbamazepine, Digoxin, Gentamicin, Lithium, N-Acetylprocainamide, Phenobarbital, Phenytoin, Procainamide, Quinidine, Salicylate, Theophylline, Tobramycin, Valproic Acid and Vancomycin assays.